Transcat, Inc. (NASDAQ:TRNS) Receives $112.20 Average PT from Analysts

Key Points

• Transcat, Inc. has received a consensus recommendation of "Moderate Buy" from five brokerages, with an average price target of $112.20.
• The company's latest quarterly earnings report indicated an EPS of $0.59, surpassing analysts' expectations of $0.40, and generated revenue of $76.42 million.
• Institutional investors hold a significant stake in Transcat, owning approximately 98.34% of the company's stock, highlighting strong investor confidence.

Transcat, Inc. (NASDAQ:TRNS - Get Free Report) has earned an average rating of "Moderate Buy" from the five ratings firms that are covering the company, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $112.20.

Several equities research analysts have commented on TRNS shares. HC Wainwright reaffirmed a "buy" rating and issued a $116.00 price target on shares of Transcat in a report on Friday, August 22nd. Lake Street Capital started coverage on shares of Transcat in a report on Thursday, July 10th. They issued a "buy" rating and a $105.00 price target on the stock. Finally, Wall Street Zen raised shares of Transcat from a "sell" rating to a "hold" rating in a report on Wednesday, May 28th.

Institutional Trading of Transcat

A number of hedge funds and other institutional investors have recently made changes to their positions in TRNS. Centiva Capital LP increased its holdings in Transcat by 6.0% in the 4th quarter. Centiva Capital LP now owns 3,009 shares of the scientific and technical instruments company's stock valued at $318,000 after purchasing an additional 171 shares during the last quarter. White Pine Capital LLC increased its holdings in Transcat by 1.7% in the 2nd quarter. White Pine Capital LLC now owns 10,175 shares of the scientific and technical instruments company's stock valued at $875,000 after purchasing an additional 171 shares during the last quarter. Bank of New York Mellon Corp increased its holdings in Transcat by 0.6% in the 1st quarter. Bank of New York Mellon Corp now owns 27,916 shares of the scientific and technical instruments company's stock valued at $2,078,000 after purchasing an additional 172 shares during the last quarter. Arkadios Wealth Advisors increased its holdings in Transcat by 3.3% in the 2nd quarter. Arkadios Wealth Advisors now owns 5,814 shares of the scientific and technical instruments company's stock valued at $500,000 after purchasing an additional 187 shares during the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in Transcat by 3.9% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 5,137 shares of the scientific and technical instruments company's stock valued at $543,000 after purchasing an additional 194 shares during the last quarter. Institutional investors and hedge funds own 98.34% of the company's stock.

Transcat Stock Performance

Shares of NASDAQ TRNS traded down $3.80 during mid-day trading on Friday, hitting $80.12. The stock had a trading volume of 105,550 shares, compared to its average volume of 101,744. The company has a debt-to-equity ratio of 0.11, a quick ratio of 2.36 and a current ratio of 2.92. The company has a 50 day moving average of $83.30 and a two-hundred day moving average of $80.87. Transcat has a twelve month low of $67.56 and a twelve month high of $133.72. The firm has a market cap of $746.72 million, a PE ratio of 56.03 and a beta of 0.72.

Transcat (NASDAQ:TRNS - Get Free Report) last released its earnings results on Wednesday, August 6th. The scientific and technical instruments company reported $0.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.19. Transcat had a return on equity of 6.66% and a net margin of 4.64%.The firm had revenue of $76.42 million for the quarter, compared to the consensus estimate of $72.28 million. Research analysts predict that Transcat will post 2.3 EPS for the current fiscal year.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.